From: Immunophenotyping invasive breast cancer: paving the road for molecular imaging
Target | Positive | Negative | Missing | |||
---|---|---|---|---|---|---|
N | % | N | % | N | % | |
HER2 | 50 | 10.4 | 432 | 89.4 | 1 | 0.2 |
EGFR | 84 | 17.4 | 395 | 81.8 | 4 | 0.8 |
MET | 43 | 8.9 | 423 | 87.6 | 17 | 3.5 |
IGF1-R | 62 | 12.8 | 400 | 82.8 | 21 | 4.3 |
GLUT1 | 98 | 20.3 | 360 | 74.5 | 25 | 5.2 |
CAIX | 46 | 9.5 | 414 | 85.3 | 25 | 5.2 |
TfR | 70 | 14.5 | 402 | 83.2 | 11 | 2.3 |
CD44v6 | 308 | 63.8 | 160 | 33.1 | 15 | 3.1 |
CAXII | 42 | 8.7 | 426 | 88.2 | 15 | 3.1 |
Mammaglobin | 81 | 16.8 | 382 | 79.1 | 20 | 4.1 |
MUC1 | 438 | 90.7 | 26 | 5.4 | 19 | 3.9 |